Your browser doesn't support javascript.
loading
Mostrar: 20 | 50 | 100
Resultados 1 - 5 de 5
Filtrar
Más filtros

Métodos Terapéuticos y Terapias MTCI
Bases de datos
Tipo del documento
País de afiliación
Intervalo de año de publicación
1.
Heart ; 94(3): 316-21, 2008 Mar.
Artículo en Inglés | MEDLINE | ID: mdl-17591648

RESUMEN

BACKGROUND: Arachidonic acid (ARA) and docosahexaenoic acid (DHA) are important components of phospholipids and cell membranes. There has, however, been no clinical report on the direct effects of ARA and DHA on coronary circulation. OBJECTIVE: To evaluate the effects of ARA and DHA on coronary circulation using the measurement of coronary flow velocity reserve (CFVR) by transthoracic Doppler echocardiography (TTDE). METHODS: A double-blind, placebo-matched study of 28 Japanese elderly individuals (19 men, mean age 65 years) conducted to compare the effects of polyunsaturated fatty acids (PUFA; ARA 240 mg/day, DHA 240 mg/day) and placebo on CFVR. Coronary flow velocity (CFV) of the left anterior descending coronary artery was measured at rest and during hyperaemia by TTDE to determine CFVR. RESULTS: There were no significant differences in CFV at rest or during hyperaemia in CFVR at baseline in the two groups (PUFA versus placebo 17 (7 SD) versus 16 (6), 62 (20) versus 59 (12), and 3.85 (1.04) versus 3.98 (0.83) cm/s, respectively). After three months' supplementation, CFV during hyperaemia was significantly higher in the PUFA than in the placebo group (73 (19) versus 64 (12) cm/s, p<0.01) although no significant difference was found between the two groups in CFV at rest (17 (7) versus 16 (4) cm/s). CFVR thus significantly increased after PUFA consumption (3.85 (1.04) versus 4.46 (0.95), p = 0.0023). CONCLUSION: Three months' supplementation of PUFA increased CFVR in Japanese elderly individuals, which suggests beneficial effects of PUFA on the coronary microcirculation.


Asunto(s)
Ácido Araquidónico/farmacología , Velocidad del Flujo Sanguíneo/efectos de los fármacos , Circulación Coronaria/efectos de los fármacos , Vasos Coronarios/efectos de los fármacos , Ácidos Docosahexaenoicos/farmacología , Anciano , Velocidad del Flujo Sanguíneo/fisiología , Circulación Coronaria/fisiología , Vasos Coronarios/diagnóstico por imagen , Vasos Coronarios/fisiología , Ecocardiografía/métodos , Ecocardiografía Doppler en Color/métodos , Métodos Epidemiológicos , Membrana Eritrocítica/diagnóstico por imagen , Membrana Eritrocítica/efectos de los fármacos , Membrana Eritrocítica/fisiología , Femenino , Humanos , Masculino
2.
Clin Nephrol ; 64(3): 236-40, 2005 Sep.
Artículo en Inglés | MEDLINE | ID: mdl-16175950

RESUMEN

A 48-year-old Japanese woman previously in good health was found to have severe proximal tubular dysfunction with a high serum level of ascorbic acid (57.3 microg/ml, reference range: 1.9 - 15.0 microg/ml). Renal biopsy specimen showed marked tubulointerstitial damage, i.e. tubular atrophy, dilatation of tubular lumen with flattened tubular epithelial cells, vacuolization of proximal and distal tubular epithelial cells, and severe interstitial fibrosis with mild infiltration of mononuclear cells. Calcified lesions, which caused tubular obstruction or stenosis, were also seen in interstitial area adjacent to degenerated proximal tubuli. Hypokalemic nephropathy, probably due to long-term use of laxatives, was clearly shown. However, calcified lesions seemed to be caused by inappropriate excessive daily ingestion of ascorbic acid (6 000 mg/day), calcium lactate, and vitamin D because of the patient's misunderstanding that these supplements could keep her in a good health. This condition may be clinically called "supplement nephropathy".


Asunto(s)
Ácido Ascórbico/efectos adversos , Compuestos de Calcio/efectos adversos , Catárticos/efectos adversos , Suplementos Dietéticos/efectos adversos , Lactatos/efectos adversos , Nefritis Intersticial/inducido químicamente , Vitamina D/efectos adversos , Vitaminas/efectos adversos , Ácido Ascórbico/administración & dosificación , Biopsia , Compuestos de Calcio/administración & dosificación , Catárticos/administración & dosificación , Relación Dosis-Respuesta a Droga , Femenino , Estudios de Seguimiento , Humanos , Glomérulos Renales/patología , Lactatos/administración & dosificación , Persona de Mediana Edad , Nefritis Intersticial/patología , Factores de Tiempo , Vitamina D/administración & dosificación , Vitaminas/administración & dosificación
3.
Dermatol Surg ; 27(7): 627-31; discussion 632, 2001 Jul.
Artículo en Inglés | MEDLINE | ID: mdl-11442612

RESUMEN

BACKGROUND: Dermabrasion and deep chemical peeling are used in the treatment of photoaged skin. These ablative procedures are effective enough to produce a certain improvement but have often caused postinflammatory hyperpigmentation among Asian patients. To avoid such adverse effects, a new, nonablative procedure has been sought. OBJECTIVE: To determine the effectiveness of photorejuvenation for Asian skin using intense pulsed light (IPL). The specific parameters used, improvement ratios, side-effects, and downtime required are also discussed. METHODS: Ninety-seven patients were treated for photoaging using IPL. The cutoff filters of 550 nm and 570 nm were utilized for three to six treatments at intervals of 2 to 3 weeks. RESULTS: Treatment results were evaluated and rated by both patients and physicians at the end of the third treatment based on improvement in pigmentation, telangiectasia, and skin texture. A combined rating of "good" or "excellent" was given to more than 90% of the patients for pigmentation, more than 83% for telangiectasia, and more than 65% for skin texture. There were some minor complications in four cases: one had erythema that continued to the next day and three had minor blisters leaving no marks. CONCLUSION: Photorejuvenation using IPL is a completely safe and effective procedure even for Asian skin. It will be increasingly used for skin rejuvenation in the future.


Asunto(s)
Pueblo Asiatico , Cara , Fototerapia , Envejecimiento de la Piel , Adulto , Anciano , Femenino , Humanos , Hiperpigmentación/terapia , Masculino , Persona de Mediana Edad , Fototerapia/efectos adversos , Fototerapia/métodos , Piel/patología , Telangiectasia/terapia
4.
Nucleic Acids Symp Ser ; (42): 131-2, 1999.
Artículo en Inglés | MEDLINE | ID: mdl-10780414

RESUMEN

The synthetic base analogue, 6H,8H-3,4-dihydropyrimido[4,5-c][1,2]oxazin-7-one (P), can efficiently base pair with A and G. We have previously demonstrated that the deoxyribonucleoside of P (dP) is highly mutagenic and that this is due to the ambiguous base pairing ability of P. In this work, we have shown that the ribonucleoside triphosphate of P (rPTP) induces C to U mutation on an in vitro model of retroviral genomic RNA replication pathway. This mutation induction by rPTP may be specific to retroviruses, since host genomic DNA should not be affected by such a ribonucleotide analogue, although temporary transcription-translation errors may occur.


Asunto(s)
Adenina , Guanina , Oxazinas , Pirimidinas , ARN Viral/genética , Retroviridae/genética , Emparejamiento Base , Secuencia de Bases , ADN Complementario/química , Mutagénesis Sitio-Dirigida , Oxazinas/química , Pirimidinas/química , Reacción en Cadena de la Polimerasa de Transcriptasa Inversa , Estereoisomerismo , Transcripción Genética
5.
Diabetes Res Clin Pract ; 36(3): 143-51, 1997 Jun.
Artículo en Inglés | MEDLINE | ID: mdl-9237780

RESUMEN

We investigated how fasting or postprandial insulin levels were altered by treatment with acarbose or sulfonylureas. Plasma glucose and serum insulin, C-peptide, and proinsulin levels were measured before as well as 1 and 2 h after breakfast in 23 patients with non-insulin-dependent diabetes mellitus and 17 patients with impaired glucose tolerance. In the diabetic patients, 12 weeks of acarbose therapy decreased the postprandial levels of glucose (1 h: -60.0%; 2 h: -67.6%), insulin (1 h: -67.5%; 2 h: -72.2%) and proinsulin (1 h: -55.2%; 2 h: -46.7%), and proinsulin (1 h: -20.9%; 2 h: -57.5%). In contrast, sulfonylurea treatment increased postprandial insulin and proinsulin levels. Since increased in the serum insulin or proinsulin levels are associated with a higher risk of cardiovascular disease, the present findings suggest that the acarbose-induced reduction of the postprandial serum insulin or proinsulin responses to food intake might be useful for preventing vascular complications in patients with diabetes.


Asunto(s)
Diabetes Mellitus Tipo 2/tratamiento farmacológico , Hiperinsulinismo/prevención & control , Hipoglucemiantes/uso terapéutico , Proinsulina/sangre , Proinsulina/efectos de los fármacos , Trisacáridos/uso terapéutico , Acarbosa , Anciano , Glucemia/efectos de los fármacos , Glucemia/metabolismo , Péptido C/sangre , Péptido C/efectos de los fármacos , Colesterol/sangre , HDL-Colesterol/sangre , HDL-Colesterol/efectos de los fármacos , Diabetes Mellitus Tipo 2/complicaciones , Ayuno , Gliclazida/uso terapéutico , Intolerancia a la Glucosa/complicaciones , Intolerancia a la Glucosa/tratamiento farmacológico , Hemoglobina Glucada/efectos de los fármacos , Hemoglobina Glucada/metabolismo , Humanos , Hiperinsulinismo/complicaciones , Insulina/sangre , Persona de Mediana Edad , Periodo Posprandial , Factores de Tiempo , Tolbutamida/uso terapéutico , Triglicéridos/sangre
SELECCIÓN DE REFERENCIAS
DETALLE DE LA BÚSQUEDA